Request Demo
Last update 05 Jul 2025
PRX-167700
Last update 05 Jul 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms PRO VAP-1 inh, PRX 167700, PRX 167700H + [1] |
Target |
Action inhibitors |
Mechanism VAP-1 inhibitors(Amine oxidase, copper containing inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC21H20N6O |
InChIKeyJFFLQACNEMRJEZ-UHFFFAOYSA-N |
CAS Registry1628780-66-4 |
Related
3
Clinical Trials associated with PRX-167700EUCTR2017-001185-20-GB
A Randomized, Double Dummy, Parallel Arm, Placebo and Active Controlled, Double Blind, Study of the Safety and Efficacy of PRX167700 as Monotherapy in Adults with Moderate to Severe Knee Pain Due to Osteoarthritis who are Inappropriate for Oral Non steroidal Anti inflammatory Therapy.
EUCTR2016-001443-39-CZ
A Randomised, Parallel Arm, Placebo-Controlled, Double-Blind, Study of the Safety and Efficacy of PRX167700 Added to Existing Non-steroidal Anti-inflammatory Therapy in Adults with Moderate-to-Severe Knee Pain Due to Osteoarthritis
NCT01945346
A Double-Blind, Randomised, Exploratory Study to Investigate the Safety, Efficacy and Pharmacokinetics of PRX167700 in Subjects With Knee Osteoarthritis.
100 Clinical Results associated with PRX-167700
Login to view more data
100 Translational Medicine associated with PRX-167700
Login to view more data
100 Patents (Medical) associated with PRX-167700
Login to view more data
100 Deals associated with PRX-167700
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Primary osteoarthritis of knee NOS | Phase 2 | United Kingdom | 01 Sep 2013 | |
| Inflammatory pain | Phase 2 | Czechia | - | |
| Inflammatory pain | Phase 2 | Hungary | - | |
| Inflammatory pain | Phase 2 | Poland | - | |
| Inflammatory pain | Phase 2 | Spain | - | |
| Inflammatory pain | Phase 2 | United Kingdom | - | |
| Pain | Phase 2 | - | - | |
| Pain | Phase 2 | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free